Christopher Moxham's most recent trade in Fulcrum Therapeutics Inc was a trade of 31,071 Stock Option (right to buy) done . Disclosure was reported to the exchange on Aug. 10, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fulcrum Therapeutics Inc | Christopher Moxham | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 31,071 | 72,501 | - | - | Stock Option (right to buy) | |
| Fulcrum Therapeutics Inc | Christopher Moxham | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 10 Aug 2021 | 31,071 | 0 (0%) | 0% | 18 | 559,278 | Common Stockm |
| Fulcrum Therapeutics Inc | Christopher Moxham | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.84 per share. | 10 Aug 2021 | 31,071 | 31,071 (0%) | 0% | 7.8 | 243,597 | Common Stock |
| Fulcrum Therapeutics Inc | Christopher Moxham | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.84 per share. | 10 Aug 2021 | 20,714 | 20,714 (0%) | 0% | 7.8 | 162,398 | Common Stock |
| Fulcrum Therapeutics Inc | Christopher Moxham | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 20,714 | 103,572 | - | - | Stock Option (right to buy) | |
| Fulcrum Therapeutics Inc | Christopher Moxham | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 10 Aug 2021 | 20,714 | 0 (0%) | 0% | 17 | 352,138 | Common Stock |
| Fulcrum Therapeutics Inc | Christopher Moxham | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 100,000 | 100,000 | - | - | Stock Option (right to buy) |